Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, Susanne Beckebaum et al.|The Lancet|2019Cited by 1.2k
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and ManagementLiangtao Ye, Florian P. Reiter, Julia S. Schneider et al.|Liver Cancer|2023Cited by 44
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case seriesChristopher Dietz-Fricke, Pietro Lampertico, Elisabetta Degasperi et al.|Hepatology|2024Cited by 36
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patientsMonika Rau, Andreas Geier|PLoS ONE|2018Cited by 6